Connor, Clark & Lunn Investment Management Ltd.

Position in FLGT — Fulgent Genetics, Inc.

CIK 1596800 VANCOUVER, A1

Back to FLGT Full portfolio

Position in FLGT

as of Mar 31, 2026 · filed May 11, 2026 Compact

Position Value

$4,810,767

-$5,035,885 QoQ

Shares Held

302,564

-19.3% QoQ

Ownership

1.07%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2021

8 quarters on record

Voting authority Sole 97.50664322259092.ToString("F0")% Shared 0.ToString("F0")% None 2.493356777409077.ToString("F0")%

Common Shares in FLGT Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

Connor, Clark & Lunn Investment Management Ltd. holds $206,312,128 across 18 Diagnostics & Research names. FLGT ranks #11 (2.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MEDP	Medpace Holdings, Inc.	134,838	$64,747,859
2	ILMN	Illumina, Inc.	202,742	$24,989,978
3	DHR	Danaher Corp /De/	129,426	$24,539,169
4	GH	Guardant Health, Inc.	254,788	$23,534,767
5	CRL	Charles River Laboratories International, Inc.	54,570	$9,413,325
6	CSTL	Castle Biosciences Inc	377,082	$9,257,363
7	ADPT	Adaptive Biotechnologies Corp	649,627	$9,016,822
8	NEO	Neogenomics Inc	938,052	$6,960,345

All Filings in FLGT

Export CSV

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$4,810,767	302,564	-19.3%	Shares	Sole	2026-05-11
2025-12-31	$9,846,652	374,825	+13.1%	Shares	Sole	2026-02-10
2025-09-30	$7,492,487	331,526	+8.6%	Shares	Sole	2025-11-13
2025-06-30	$6,066,978	305,180	+22.2%	Shares	Sole	2025-08-07
2025-03-31	$4,219,237	249,659	+98.2%	Shares	Sole	2025-05-12
2024-12-31	$2,326,425	125,957	+803.2%	Shares	Sole	2025-02-10
2024-09-30	$303,046	13,946	+109.7%	Shares	Sole	2024-11-08
2021-12-31	$668,822	6,649	—	Shares	Sole	2022-02-10
No filing history on record for this holder in this stock.